Statistics for A phase II study of buparlisib in relapsed or refractory thymomas
Total visits
| views | |
|---|---|
| A phase II study of buparlisib in relapsed or refractory thymomas | 2 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:1b05812c-9d1f-4402-8f97-b7921cf80c9d | 41 |
| java.util.UUID:7b98a09b-21c4-4032-901b-d0c3302f53e5 | 16 |
| AbuZaid2022PhaseII-CCBY.pdf | 14 |
| java.util.UUID:db963f3f-eb04-4a9b-bfa7-ab6e562b4b3a | 7 |
Top country views
| views | |
|---|---|
| United States | 2 |
Top city views
| views | |
|---|---|
| Indianapolis | 2 |